Last updated on November 2018

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

Brief description of study

The purpose of this study is to determine the safety and effectiveness of ulocuplumab in combination with low dose cytarabine in the treatment of Newly Diagnosed Acute Myeloid Leukemia (AML).

Clinical Study Identifier: NCT02305563

Contact Investigators or Research Sites near you

Start Over

Site 0046

Local Institution
New Taipei City, Taiwan

Site 0020

Local Institution
Taipei, Taiwan